Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for MDxHealth (MDXH) over the last 5 years, with Dec 2024 value amounting to $99.8 million.

  • MDxHealth's Total Non-Current Liabilities rose 17.40% to $111.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $437.2 million, marking a year-over-year increase of 10.49%. This contributed to the annual value of $99.8 million for FY2024, which is 2.52% down from last year.
  • As of FY2024, MDxHealth's Total Non-Current Liabilities stood at $99.8 million, which was down 2.52% from $102.4 million recorded in FY2023.
  • MDxHealth's Total Non-Current Liabilities' 5-year high stood at $102.4 million during FY2023, with a 5-year trough of $11.7 million in FY2021.
  • Over the past 3 years, MDxHealth's median Total Non-Current Liabilities value was $95.7 million (recorded in 2022), while the average stood at $92.5 million.
  • Per our database at Business Quant, MDxHealth's Total Non-Current Liabilities fell by 9.59% in 2021 and then soared by 679.68% in 2022.
  • Over the past 5 years, MDxHealth's Total Non-Current Liabilities (MRY) stood at $13.0 million in 2020, then fell by 9.59% to $11.7 million in 2021, then soared by 679.68% to $91.5 million in 2022, then grew by 11.86% to $102.4 million in 2023, then dropped by 2.52% to $99.8 million in 2024.
  • Its Total Non-Current Liabilities stands at $99.8 million for FY2024, versus $102.4 million for FY2023 and $91.5 million for FY2022.